Phase 3 Bunionectomy Study

NCT07490496 · tracked via the Priya Life Science USA tracker

Sponsor

Cali Pharmaceuticals LLC

Phase

Phase 3

Started

2026-07-01

Last updated

2026-03-27

Condition(s) studied

Postoperative PainBunion

Investigational drug(s) / intervention(s)

CPL-01saline placebo

CPL-01: Administration by the Surgeon during the operation

saline placebo: Administration by the Surgeon during the operation

Study summary

Patients with a bunion will have that repaired and then pain and rescue medicine use will be evaluated.

Eligibility

Sex

ALL

Min age

18 Years

Max age

75 Years

Healthy volunteers

Inclusion Criteria: * Bunion Exclusion Criteria: * Concomitant conditions

Primary outcome measure(s)

Postoperative Pain with activity — 24 hours
AUC NRS-A wWOCF (Area Under the Curve of the Numeric Rating Scale sore for pain with Activity where 0 is no pain and 10 is worst pain imaginable)

Trial sites (1)

Facility	City	Region	Status
CenExel	Salt Lake City	Utah

Other trials for the same condition

Early Weight-Bearing After the Lapiplasty Procedure Active, not recruiting

A Study of TLC590 for Postsurgical Pain Following Bunionectomy Active, not recruiting

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery Recruiting

Patient Satisfaction and Recovery Outcomes Associated With Perioperative ELIXIR MD Use Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07490496 on ClinicalTrials.gov ↗ ← All trials in the USA